ULTRAGENYX PHARMACEUTICAL IN

Ticker: RARE CUSIP: 90400D108 Class: EQTY

OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM's Holding History (CIK: 0001132716)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 31,861 Value ($000) $1,158 Avg Close $36.05 Range $29.59 - $40.19
Q1 2025
Shares 87,811 Value ($000) $3,180 Avg Close $41.60 Range $35.53 - $46.50
Q4 2024
Shares 22,284 Value ($000) $937 Avg Close $49.61 Range $41.26 - $57.99
Q3 2024
Shares 21,269 Value ($000) $1,181 Avg Close $50.94 Range $39.65 - $60.37
Q2 2024
Shares 35,128 Value ($000) $1,444 Avg Close $42.70 Range $37.02 - $52.56
Q1 2024
Shares 42,606 Value ($000) $1,989 Avg Close $47.17 Range $41.87 - $54.56
Q4 2023
Shares 56,956 Value ($000) $2,724 Avg Close $38.77 Range $31.52 - $49.93
Q3 2023
Shares 76,915 Value ($000) $2,742 Avg Close $39.62 Range $34.33 - $47.08
Q2 2023
Shares 67,348 Value ($000) $3,107 Avg Close $46.38 Range $37.20 - $54.98
Q1 2023
Shares 59,276 Value ($000) $2,377 Avg Close $42.91 Range $35.72 - $49.31
Q1 2015
Shares 20,000 Value ($000) $1,242,000 Avg Close $55.55 Range $44.27 - $65.35
Q4 2014
Shares 25,000 Value ($000) $1,097,000 Avg Close $45.82 Range $38.01 - $58.33